AVTX
Avalo Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD13.74
-0.22 (-1.58%)
Rating:C
Company Profile
CEO
Garry A. Neil
IPO Date
2015-10-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$14.20
Prev. Close
$13.96
Day Low
$13.65
Day High
$14.71
52W Low
$4.06
52W High
$24.27
Market Cap
$0.16B
Volume
2.52M